MARKET

TEVA

TEVA

Teva Pharm
NYSE
16.53
-0.43
-2.54%
Opening 15:40 06/24 EDT
OPEN
16.88
PREV CLOSE
16.96
HIGH
16.90
LOW
16.46
VOLUME
6.13M
TURNOVER
0
52 WEEK HIGH
17.69
52 WEEK LOW
7.40
MARKET CAP
18.72B
P/E (TTM)
-37.5341
1D
5D
1M
3M
1Y
5Y
UPDATE 2-Teva launches generic version of Novo Nordisk's diabetes drug Victoza
Teva launches a generic version of Novo Nordisk's diabetes drug Victoza to treat patients with type 2 diabetes. The drug is the first generic GLP-1 drug in the United States. Growing popularity of the drug class has led to shortages in the U.S.
Reuters · 6h ago
Teva Launches Authorized Generic Of Victoza For Type 2 Diabetes Patients In US
NASDAQ · 6h ago
Teva launches authorized generic of Victoza for diabetes, cardiovascular treatment in the U.S.
Seeking Alpha · 7h ago
BRIEF-Teva Announces Launch Of Authorized Generic Of Victoza In The U.S.
Teva Announces Launch Of Authorized Generic Of Victoza In The U.S. Teva says drug is designed to improve control in adults and teenagers. The drug had annual sales of $1.656 billion as of April 2024. The generic is available in the United States.
Reuters · 8h ago
Teva Pharmaceutical Industries Launches Authorized Generic Of Victoza In United States
Generic Victoza is the first-ever generic GLP-1. Liraglutide injection is indicated to improve glycemic control in adults and pediatric patients with type 2 diabetes mellitus. The launch supports increased demand for this category of therapies in the U.S.
Benzinga · 8h ago
TEVA: VICTOZA HAD ANNUAL SALES OF $1.656 BLN AS OF APRIL 2024
Reuters · 8h ago
Here's Why You Should Consider Buying Alvotech (ALVO) Stock
NASDAQ · 8h ago
Weekly Report: what happened at TEVA last week (0617-0621)?
Weekly Report · 12h ago
More
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Webull offers Teva Pharmaceutical Industries Ltd (ADR) stock information, including NYSE: TEVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TEVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TEVA stock methods without spending real money on the virtual paper trading platform.